XML 43 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities    
Net income $ 35,047 $ 35,590
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 9,001 8,527
Amortization 2,283 1,596
Equity in undistributed earnings of associated companies, net of dividends (428) (136)
Deferred compensation and other, net 1,848 6,987
Stock-based compensation 2,954 2,675
Non cash gain from purchase of equity affiliate 0 (2,718)
Gain on disposal of property, plant and equipment (75) (61)
Insurance settlement realized (1,074) (1,242)
Pension and other postretirement benefits (1,823) (4,099)
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable (1,381) (29,390)
Inventories (875) (16,334)
Prepaid expenses and other current assets (1,976) (3,061)
Accounts payable and accrued liabilities (1,731) 6,196
Net cash provided by operating activities 41,770 4,530
Cash flows from investing activities    
Investments in property, plant and equipment (8,757) (8,914)
Payments related to acquisitions, net of cash acquired (2,635) (10,981)
Proceeds from disposition of assets 193 221
Insurance settlement received and interest earned 53 61
Change in restricted cash, net 1,021 1,181
Net cash used in investing activities (10,125) (18,432)
Cash flows from financing activities    
Net increase in short-term borrowings 0 (185)
Repayment of long-term debt (9,672) (30,613)
Dividends paid (9,410) (8,492)
Stock options exercised, other (828) 629
Excess tax benefit related to stock option exercises 2,164 153
Proceeds from sale of common stock, net of related expenses 0 48,143
Distributions to noncontrolling shareholders (30) 0
Net cash (used in) provided by financing activities (17,776) 9,635
Effect of exchange rate changes on cash (606) (920)
Net increase (decrease) in cash and cash equivalents 13,263 (5,187)
Cash and cash equivalents at beginning of period 16,909 25,766
Cash and cash equivalents at end of period $ 30,172 $ 20,579